DUPONT CAPITAL MANAGEMENT CORP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 283 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.89 and the average weighting 0.3%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$56,032
-47.4%
2,206
-16.0%
0.00%
-40.0%
Q4 2022$106,511
+3.4%
2,626
-15.5%
0.01%
-16.7%
Q3 2022$103,000
-29.5%
3,108
-25.1%
0.01%
-14.3%
Q2 2022$146,000
-23.6%
4,1500.0%0.01%
-12.5%
Q1 2022$191,000
-33.4%
4,150
-4.1%
0.01%
-20.0%
Q4 2021$287,000
-34.2%
4,328
-38.1%
0.01%
-28.6%
Q3 2021$436,000
-48.6%
6,991
-31.7%
0.01%
-30.0%
Q2 2021$848,000
+33.3%
10,236
+6.7%
0.02%
+33.3%
Q1 2021$636,000
-14.5%
9,592
-1.1%
0.02%
-6.2%
Q4 2020$744,000
+7.7%
9,701
-39.6%
0.02%
+6.7%
Q3 2020$691,000
-29.7%
16,050
-29.5%
0.02%
-31.8%
Q2 2020$983,000
+158.7%
22,754
+72.1%
0.02%
+144.4%
Q1 2020$380,000
-72.8%
13,221
-40.0%
0.01%
-71.0%
Q4 2019$1,397,000
+125.3%
22,0190.0%0.03%
+121.4%
Q3 2019$620,00022,0190.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders